Atmospheric Environment, ISSN 1352-2310, 12/2017, Volume 171, pp. 173 - 180
Measurement campaigns at the high mountain Observatory Mt. Cimone (CMN; 2165 m a.s.l.) were performed during May 2014 and October 2015. The concentration of...
Activated fraction | Condensation nucleation | Ice nucleating particles | Deposition nucleation | ALPINE SITE JUNGFRAUJOCH | MINERAL DUST | ENVIRONMENTAL SCIENCES | TRANSPORT | PHASE | GLOBAL STATION | NUCLEI | PARAMETERIZATION | CHEMICAL-COMPOSITION | METEOROLOGY & ATMOSPHERIC SCIENCES | PO VALLEY | WATER | Tracers (Chemistry) | Analysis | Measuring instruments
Activated fraction | Condensation nucleation | Ice nucleating particles | Deposition nucleation | ALPINE SITE JUNGFRAUJOCH | MINERAL DUST | ENVIRONMENTAL SCIENCES | TRANSPORT | PHASE | GLOBAL STATION | NUCLEI | PARAMETERIZATION | CHEMICAL-COMPOSITION | METEOROLOGY & ATMOSPHERIC SCIENCES | PO VALLEY | WATER | Tracers (Chemistry) | Analysis | Measuring instruments
Journal Article
Atmospheric Environment, ISSN 1352-2310, 04/2014, Volume 87, pp. 218 - 227
Nocturnal organic and inorganic chemical characterization of fine (PM ) aerosol was carried out at the GAW global high mountain station of Mt. Cimone (CMN),...
Mediterranean basin | Chemical composition | Residual layers | PM1 aerosol | Free troposphere | Po Valley | VALLEY | COMPONENTS | SEASONAL-VARIATION | CLOSURE | AEROSOL MASS | P 5079 M | ENVIRONMENTAL SCIENCES | POLLUTION | PUY | METEOROLOGY & ATMOSPHERIC SCIENCES
Mediterranean basin | Chemical composition | Residual layers | PM1 aerosol | Free troposphere | Po Valley | VALLEY | COMPONENTS | SEASONAL-VARIATION | CLOSURE | AEROSOL MASS | P 5079 M | ENVIRONMENTAL SCIENCES | POLLUTION | PUY | METEOROLOGY & ATMOSPHERIC SCIENCES
Journal Article
Astronomy and Astrophysics, ISSN 0004-6361, 05/2016, Volume 589, p. A45
Context. Studying the coma environment of comet 67P/Churyumov-Gerasimenko (67P) is one of the primary scientific goals of the VIRTIS experiment on the ESA...
Techniques: imaging spectroscopy | Comets: individual: 67P/CG | comets: individual: 67P/CG | SPECTROMETER | ROSETTA | FLUORESCENCE | H2O | NUCLEUS | ASTRONOMY & ASTROPHYSICS | CO2 | ICE | techniques: imaging spectroscopy | Comet heads | Comets | Equatorial regions | Comet nuclei | Carbon dioxide | Latitude | Vapour | Altitude
Techniques: imaging spectroscopy | Comets: individual: 67P/CG | comets: individual: 67P/CG | SPECTROMETER | ROSETTA | FLUORESCENCE | H2O | NUCLEUS | ASTRONOMY & ASTROPHYSICS | CO2 | ICE | techniques: imaging spectroscopy | Comet heads | Comets | Equatorial regions | Comet nuclei | Carbon dioxide | Latitude | Vapour | Altitude
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 9, pp. 1036 - 1045
Abstract Background The incidence, predictors, and prognostic impact of post-discharge bleeding (PDB) after percutaneous coronary intervention (PCI) with...
Cardiovascular | Internal Medicine | late bleeding | mortality | platelet reactivity | HARMONIZING OUTCOMES | CARDIAC & CARDIOVASCULAR SYSTEMS | ACUTE CATHETERIZATION | RANDOMIZED-TRIALS | MYOCARDIAL-INFARCTION TRIALS | NETWORK METAANALYSIS | CLOPIDOGREL | DUAL ANTIPLATELET THERAPY | TREATMENT PLATELET REACTIVITY | ELUTING STENT IMPLANTATION | DURATION | Multivariate Analysis | Predictive Value of Tests | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Patient Discharge | Drug-Eluting Stents - adverse effects | Dose-Response Relationship, Drug | Percutaneous Coronary Intervention - methods | Adult | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Postoperative Hemorrhage - mortality | Drug Administration Schedule | Postoperative Care - adverse effects | Risk Assessment | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Care - methods | Radiography | Postoperative Hemorrhage - etiology | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Survival Analysis | Aged | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Sects | Medical colleges | Heart attacks | Cardiology | Stents | Mortality
Cardiovascular | Internal Medicine | late bleeding | mortality | platelet reactivity | HARMONIZING OUTCOMES | CARDIAC & CARDIOVASCULAR SYSTEMS | ACUTE CATHETERIZATION | RANDOMIZED-TRIALS | MYOCARDIAL-INFARCTION TRIALS | NETWORK METAANALYSIS | CLOPIDOGREL | DUAL ANTIPLATELET THERAPY | TREATMENT PLATELET REACTIVITY | ELUTING STENT IMPLANTATION | DURATION | Multivariate Analysis | Predictive Value of Tests | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Patient Discharge | Drug-Eluting Stents - adverse effects | Dose-Response Relationship, Drug | Percutaneous Coronary Intervention - methods | Adult | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Postoperative Hemorrhage - mortality | Drug Administration Schedule | Postoperative Care - adverse effects | Risk Assessment | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Care - methods | Radiography | Postoperative Hemorrhage - etiology | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Survival Analysis | Aged | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Sects | Medical colleges | Heart attacks | Cardiology | Stents | Mortality
Journal Article
Nature, ISSN 0028-0836, 2017, Volume 550, Issue 7675, pp. 204 - 213
Characterization of the molecular function of the human genome and its variation across individuals is essential for identifying the cellular mechanisms that...
FALSE DISCOVERY RATE | TRANS-EQTLS | VARIANTS | MULTIDISCIPLINARY SCIENCES | DISEASE | LOCI | PHENOTYPES | IDENTIFICATION | TRANSCRIPTION FACTOR | HYPOTHYROIDISM | GENOME-WIDE ASSOCIATION | Disease - genetics | Gene Expression Regulation - genetics | Chromosomes, Human - genetics | Humans | Genotype | Male | Gene Expression Profiling | Genome, Human - genetics | Genetic Variation | Organ Specificity - genetics | Alleles | Female | Quantitative Trait Loci - genetics | Studies | Genetic effects | Proteins | Genotype & phenotype | Disease | Genes | Gene regulation | Genomes | Genetic diversity | Gene expression | Tissues | Human tissues | Transcriptomics
FALSE DISCOVERY RATE | TRANS-EQTLS | VARIANTS | MULTIDISCIPLINARY SCIENCES | DISEASE | LOCI | PHENOTYPES | IDENTIFICATION | TRANSCRIPTION FACTOR | HYPOTHYROIDISM | GENOME-WIDE ASSOCIATION | Disease - genetics | Gene Expression Regulation - genetics | Chromosomes, Human - genetics | Humans | Genotype | Male | Gene Expression Profiling | Genome, Human - genetics | Genetic Variation | Organ Specificity - genetics | Alleles | Female | Quantitative Trait Loci - genetics | Studies | Genetic effects | Proteins | Genotype & phenotype | Disease | Genes | Gene regulation | Genomes | Genetic diversity | Gene expression | Tissues | Human tissues | Transcriptomics
Journal Article
ASTRONOMY & ASTROPHYSICS, ISSN 1432-0746, 09/2019, Volume 630, p. A23
Context. On 27 April 2015, when comet 67P/Churyumov-Gerasimenko was at 1.76 au from the Sun and moving toward perihelion, the OSIRIS and VIRTIS-M instruments...
SYSTEM | methods: data analysis | H2O | SUBLIMATION | WATER ICE | MODEL | 67P | ORIGIN | NUCLEUS | ASTRONOMY & ASTROPHYSICS | REGIONS | comets: individual: 67P/Churyumov-Gerasimenko | comets: general | PERIHELION | Sciences of the Universe | Astrophysics
SYSTEM | methods: data analysis | H2O | SUBLIMATION | WATER ICE | MODEL | 67P | ORIGIN | NUCLEUS | ASTRONOMY & ASTROPHYSICS | REGIONS | comets: individual: 67P/Churyumov-Gerasimenko | comets: general | PERIHELION | Sciences of the Universe | Astrophysics
Journal Article
7.
Full Text
Properties of the dust in the coma of 67P/Churyumov-Gerasimenko observed with VIRTIS- M
Monthly Notices of the Royal Astronomical Society, ISSN 0035-8711, 2016, Volume 462, pp. S547 - S561
An investigation is presented of the dust scattering in the coma of 67P/Churyumov-Gerasimenko for the dates of 2015 February 28, March 15 and April 27. A...
Comets: individual: 67P/Churyumov-Gerasimenko | Methods: observational | Methods: data analysis | Techniques: imaging spectroscopy | SPECTROMETER | methods: observational | methods: data analysis | KINETICS | COLOR | ASTRONOMY & ASTROPHYSICS | ROSETTA MISSION | GAS | comets: individual: 67P/Churyumov-Gerasimenko | HALLEY | COMETARY COMA | P/HALLEY | techniques: imaging spectroscopy | SCATTERING | WATER
Comets: individual: 67P/Churyumov-Gerasimenko | Methods: observational | Methods: data analysis | Techniques: imaging spectroscopy | SPECTROMETER | methods: observational | methods: data analysis | KINETICS | COLOR | ASTRONOMY & ASTROPHYSICS | ROSETTA MISSION | GAS | comets: individual: 67P/Churyumov-Gerasimenko | HALLEY | COMETARY COMA | P/HALLEY | techniques: imaging spectroscopy | SCATTERING | WATER
Journal Article
The European Physical Journal C: Particles and Fields, ISSN 1434-6052, 2017, Volume 77, Issue 5, pp. 1 - 53
During 2015 the ATLAS experiment recorded $$3.8\,{\mathrm{fb}}^{-1}$$ 3.8 fb - 1 of proton–proton collision data at a centre-of-mass energy of...
PHYSICS, PARTICLES & FIELDS | Collisions (Nuclear physics) | Protons | Data acquisition systems | Physics - High Energy Physics - Experiment | High Energy Physics - Phenomenology | Physics | PARTICLE ACCELERATORS | Regular - Experimental Physics | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
PHYSICS, PARTICLES & FIELDS | Collisions (Nuclear physics) | Protons | Data acquisition systems | Physics - High Energy Physics - Experiment | High Energy Physics - Phenomenology | Physics | PARTICLE ACCELERATORS | Regular - Experimental Physics | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
Science (New York, N.Y.), 06/2018, Volume 360, Issue 6392, p. 1003
The moment magnitude ( ) 5.5 earthquake that struck South Korea in November 2017 was one of the largest and most damaging events in that country over the past...
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The...
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article